Navigation Links
US FDA approved Aurobindo Pharma to produce generic AIDS drug

The US Food and Drug Association (FDA) has approved Aurobindo Pharma Limited to produce the generic version of oral Stavudine solution// 1 mg/mL, which is used in children for control of HIV treatment. Zerit (Stavudine Oral solution) is produced commercially by Bristol-Myers Squibb which has the patent for the drug which is found to be very effective against HIV. Stavudine is a synthetic thymidine nucleoside analogue. The generic version approved for Aurobindo pharma manufacture could be given in HIV treatment to children’s from childhood to adolescent age. The drug Stavudine acts by inhibiting the cell division of the HIV by inhibiting its reverse transcriptase enzyme which is required for the virus replication. Aurobindo Pharmaceuticals is present in India which is involved in the manufacturing of generic and active pharmaceutical drugs.
'"/>




Page: 1

Related medicine news :

1. Abortion Pill approved by FDA
2. Another injectable contraceptive Pill approved by FDA
3. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
4. New oral antiviral treatment of cold sores approved
5. Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India
6. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
7. Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki
8. IGF-1 drug approved by FDA
9. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
10. Thalidomide is the new approved drug for treating multiple cancers
11. Tamiflu drug approved in Europe for children’

Post Your Comments:
(Date:12/3/2009).... 3 According to the World Health ..."Swine Flu") has reached a pandemic level. Over 5... least 6,500 fatalities. Since there is no longer..., these numbers undoubtedly understate the real si...cgi-bin/prnh/20091203/NY20654 ) ,, There are c...
(Date:12/3/2009)...tts Does Little to Make Lung Cancer a State Public...swire-USNewswire/ -- Today, Lung Cancer Alliance...ort Card on Lung Cancer . The 2009 Report Card is... lethal disease in the state of Massachusetts. LC...he only national organization dedicated exclusivel...
(Date:12/3/2009)...y, PARSIPPANY, N.J. and ANDOVER, Mass., Dec. 3 /PR...Image Intelligence® company, and Visage Imagi...dicus Ltd. (ASX: PME) announced today that they ha...nd market advanced oncology solutions for the clin...tnership enables Definiens to utilize the Visage&#...
(Date:12/3/2009)...3 The following is bein..., U.S. Senate Judiciary Committee Chairman Patri...ealth care reform bill that would repeal the healt...ions such as price fixing, bid rigging and market ...s the repeal, which would subject health insurance...
(Date:12/3/2009)... An exciting treatment gaining acce...platelet-rich plasma therapy (PRP), is showing str...plant procedures, according to a prominent dental ...antology . ,, James Rutkowski, DMD, PhD, repo...e American Academy of Implant Dentistry that plate...
Breaking Medicine News(10 mins):Health News:Buchang Global Health Forum 2009: An Innovative Approach for Management of H1N1 Swine Flu 2Health News:Lung Cancer Alliance-Massachusetts Releases 3rd Annual State-Specific Report Card on Lung Cancer 2Health News:Visage Imaging and Definiens Announce Partnership 2Health News:Visage Imaging and Definiens Announce Partnership 3Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 2Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 3Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 4Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 5Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 6Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 7Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 8Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2
..., Va., March 9 CEL-SCI Corporation (NYSE Alternex...o an exclusive licensing agreement with Byron Biop...ron an exclusive license to market and distribute ...kine with Teva Pharmaceuticals and Orient Europhar...
...TON, Ky., March 9 VirtualHealth Technologies, Inc...effective immediately it,s subsidiary Envoii Healt..., LLC to better reflect it,s focus on eHealth Secu...mmitment on growing our opportunities in this evol...
...nique eases pressure on local nerves, researchers ...- A shot of ozone and oxygen may prove to be a saf...ain of a herniated disk, U.S. researchers say. , ...ord nerves. The standard treatments for severe pai...
...RUNSWICK, N.J., March 9 Savient Pharmaceuticals, ...amelin, President of Savient Pharmaceuticals will ...th Annual Healthcare Conference. , , The presenta...ston, MA, March 16-19, 2009. , , Individuals can ...
...of Daylight Saving Time Declared ,Vitamin D Day, t...amin , , WASHINGTON, March 9 As we get ready to ...tional Milk Mustache "got milk?" Campaign is decla... D when the ultraviolet rays of the sun hit our sk...
...ements Provide Safer, Faster, and Easier Treatment...S Nordion, a leading provider of medical isotopes ...ch of an improved administration system for TheraS... the administration system allow for safer, faster...
Other Medicine News:Health News:CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa 2Health News:Envoii Healthcare, LLC is now Secure eHealth, LLC 2Health News:Envoii Healthcare, LLC is now Secure eHealth, LLC 3Health News:Ozone/Oxygen Shot Helps Heal Herniated Disk 2Health News:Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009 2Health News:Vitamin D Deficiency Has Emerged as a Silent Epidemic 2Health News:Vitamin D Deficiency Has Emerged as a Silent Epidemic 3Health News:Vitamin D Deficiency Has Emerged as a Silent Epidemic 4Health News:MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians 2Health News:MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians 3
(Date:12/3/2009)...RT WORTH, Texas, Dec. 3 /PRNewswire-FirstCall/ -...tin Board: WNDM), a rapidly growing provider of sp...ment with the Health Industry Representative Assoc...ent sales and marketing representative to market t...in the U.S. ,, HIRA will market and sell Wound...
(Date:12/3/2009)...N.C., Dec. 3 In respons...information technologies in the evolving healthcar...uke Center for Health Informatics (DCHI) to provid... oversee an innovative interdisciplinary approach ... physicians, nurses and healthcare administrators ...
(Date:12/3/2009)..., Calif., Dec. 3 TROY Group, Inc....Solutions, announces the addition of the TROY 301...ription printing solutions. Based on the HP LaserJ...cureRx(TM) Printers provide a fast 42 page per min...ting capability and enhanced TROY prescription sec...
Breaking Medicine Technology:Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3New TROY SecureRx Prescription Printer Marks 50th Hospital Installation Milestone 22009 Special Olympics Minnesota Summer Games 48333 12009 Special Olympics Minnesota Summer Games 48333 22009 Special Olympics Minnesota Summer Games 48333 3New study indicates radiologists need standards to ensure optimal visual accuracy 48331 1New accurate diagnostic test for swine H1N1 influenza using RT PCR technology 48329 1New accurate diagnostic test for swine H1N1 influenza using RT PCR technology 48329 2
...5698 advance in clinical development for the ...PHILADELPHIA and SAN FRANCISCO, Jan. 3 /PRNewswire...heravance, Inc. (Nasdaq: THRX ) today,announced t...n studies with,both the lead inhaled corticosteroi...eta agonist (LABA) GW642444 (,444) assets in the ,...
...Zeneca (NYSE:,AZN) today announced that the compan... Applications (sNDAs) to the U.S. Food and Drug,Ad...(quetiapine fumarate),Extended-Release Tablets to ...associated with bipolar disorder and the treatment...sorder., The bipolar mania submission is based on...
Other Medicine Technology:GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program 2GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program 3GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program 4GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program 5AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 2AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 3AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 4AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 5AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 6AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 7
FirstChoice Drainable Pouches, Convex
FirstChoice Drainable Pouch, FlexWear, Cut-to-Fit
FirstChoice Drainable Kit
FirstChoice Closed Pouches
Medicine Products: